MRVL · Verdict

A summary of rules, not a profit forecast — don’t buy just because of a green verdict.

• ▼ P/E 64.6 vs peer median 33.8 — more expensive than peers
• ▼ P/S 18.7 — expensive for this stock (over 7 y: from 6.0 to 16.9)
• ▼ P/S 18.7 vs peer median 16.3 — more expensive than peers
• ▼ EV/EBITDA 60.9 vs peer median 27.4 — more expensive than peers
• ▼ FCF yield 0.8% — expensive for this stock (over 7 y: from 1.2% to 2.9%)
• ▼ FCF yield 0.8% vs peer median 2.0% — more expensive than peers
• ▼ Cyclical company at peak earnings: P/E 64.6 is understated; on average earnings over 7 y it is 630.6
• ▲ Forward P/E 26.8 is below the current one — earnings growth expected

• ▲ Piotroski 8/9 — strong financial health
• ▲ ROE 17% — high return on equity
• ▲ Net margin rose: -2.8% → 32.6%
• ▲ Debt / equity 0.33 — moderate debt
• ▲ Free cash flow positive every year

• ▲ Revenue grows 22.5% per year (5 y)
• ▲ Analysts raised the earnings forecast by +4.1% in 90 days

• ▲ Over 6 mo stronger than its sector (XLK) by 6%
• ▲ Price above SMA200 — long-term uptrend
• ▲ SMA50 above SMA200 — trend up
• ▲ Over a year +122% vs S&P 500 +11% — stronger than the market

• ▼ Volatility 82% per year — much higher than the market (13%)
• ▼ Max drawdown in the period -62% — deep
• ▼ Beta 2.26 — moves more than the market

• ▲ Consensus of 44 analysts — buy
• ▲ Mean analyst target +73% from the current price
• ▲ Insiders buying over 6 mo

• ▲ S&P 500 above SMA200 — the market is in an uptrend
• ▲ Sector (XLK) above SMA200 — in an uptrend